Ophthalmic antiallergics
Eye drops for itchy allergic eyes: antihistamines that also steady mast cells (olopatadine, ketotifen) and pure mast cell stabilisers.
What they are
Topical drugs for allergic conjunctivitis caused by pollen, dust, animal dander and similar allergens. Dual-action drops block H1 receptors for fast relief of itching and also reduce mast cell release, which helps prevent new symptoms.
Mechanism of action
In allergic conjunctivitis allergen binds IgE on conjunctival mast cells, which release histamine and other mediators. Histamine on H1 receptors causes itching, redness and swelling. Olopatadine and ketotifen block H1 receptors and stabilise mast cells; cromoglicate-type drugs only stabilise mast cells and work best when started before exposure.
Target: Histamine H1 receptors and conjunctival mast cells
Drugs in this class
- OlopatadineAn antihistamine eye drop that also steadies mast cells. It relieves the itch of allergic conjunctivitis caused by…Histamine H1 receptor (plus mast cell stabilisation)
- KetotifenAn antihistamine eye drop that also steadies mast cells. It relieves the itch of allergic conjunctivitis for several…Histamine H1 receptor (plus mast cell stabilisation)
Others in the class
- Azelastine, epinastine, alcaftadine, bepotastine (antihistamine drops)
- Sodium cromoglicate, lodoxamide, nedocromil (mast cell stabilisers)
Test yourself
Think of the answer, then tap the question to see it.
Which symptom is the hallmark of allergic conjunctivitis?
Itching.
What two actions do olopatadine and ketotifen share?
H1 receptor blockade and mast cell stabilisation.
Why are pure mast cell stabilisers started before the allergy season?
They prevent mediator release but do not block histamine that is already released.
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: Olopatadine Ophthalmic: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); Ketotifen Ophthalmic: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.